Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Antibiotics (Basel, Switzerland)|June 26, 2026
The ESKAPE Challenge: Understanding Resistance and Exploring Alternative TreatmentsKartika Vashishtha, Pobitra Borah, Robert Sonowal
World Journal of Diabetes|October 3, 2022
Evolving spectrum of diabetic wound: Mechanistic insights and therapeutic targetsRaja Chakraborty, Pobitra Borah, Partha Pratim Dutta, et al.
Current Pharmaceutical Design|July 24, 2019
P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the FuturePobitra Borah, Satyendra Deka, Raghu Prasad Mailavaram, et al.
Human Vaccines & Immunotherapeutics|December 3, 2021
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?Gaurav Joshi, Pobitra Borah, Shweta Thakur, et al.
Current Pharmaceutical Design|May 3, 2023
Icacinaceae Plant Family: A Recapitulation of the Ethnobotanical, Phytochemical, Pharmacological, and Biotechnological AspectsSangeeta Hazarika, Pobitra Borah, Pran Kishore Deb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 1, 2021
In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosisPran Kishore Deb, Nizar A Al-Shar'i, Katharigatta N Venugopala, et al.
Current Drug Metabolism|July 16, 2020
Application of Advanced Technologies in Natural Product Research: A Review with Special Emphasis on ADMET ProfilingPobitra Borah, Sangeeta Hazarika, Satyendra Deka, et al.
Current Medicinal Chemistry|September 9, 2020
Current Scenario and Future Prospect in the Management of COVID-19Pobitra Borah, Pran Kishore Deb, Satyendra Deka, et al.
Current Drug Metabolism|July 6, 2021
ADMET Profiling in Drug Discovery and Development: Perspectives of In Silico, In Vitro and Integrated ApproachesNour El-Huda Daoud, Pobitra Borah, Pran Kishore Deb, et al.
Pageof 3